In the mid-nineteen-forties,
Robert Spitzer, a mathematically minded boy of
fifteen, began weekly sessions of Reichian
psychotherapy. Wilhelm Reich was an Austrian
psychoanalyst and a student of Sigmund Freud who,
among other things, had marketed a device that he
called the orgone accumulator—an iron appliance,
the size of a telephone booth, that he claimed
could both enhance sexual powers and cure cancer.
Spitzer had asked his parents for permission to
try Reichian analysis, but his parents had
refused—they thought it was a sham—and so he
decided to go to the sessions in secret. He paid
five dollars a week to a therapist on the Lower
East Side of Manhattan, a young man willing to
talk frankly about the single most compelling
issue Spitzer had yet encountered: women. Spitzer
found this methodical approach to the enigma of
attraction both soothing and invigorating. The
real draw of the therapy, however, was that it
greatly reduced Spitzer’s anxieties about his
troubled family life: his mother was a
“professional patient” who cried continuously, and
his father was cold and remote. Spitzer,
unfortunately, had inherited his mother’s unruly
inner life and his father’s repressed affect;
though he often found himself overpowered by
emotion, he was somehow unable to express his
feelings. The sessions helped him, as he says,
“become alive,” and he always looked back on them
with fondness. It was this experience that
confirmed what would become his guiding principle:
the best way to master the wilderness of emotion
was through systematic study and analysis.
Robert Spitzer isn’t widely known outside the
field of mental health, but he is, without
question, one of the most influential
psychiatrists of the twentieth century. It was
Spitzer who took the Diagnostic
and Statistical Manual of Mental
Disorders—the official listing of all
mental diseases recognized by the American
Psychiatric Association (A.P.A.)—and established
it as a scientific instrument of enormous power.
Because insurance companies now require a DSM diagnosis for
reimbursement, the manual is mandatory for any
mental-health professional seeking compensation.
It’s also used by the court system to help
determine insanity, by social-services agencies,
schools, prisons, governments, and, occasionally,
as a plot device on “The Sopranos.” This magnitude
of cultural authority, however, is a relatively
recent phenomenon. Although the DSM was first published in
1952 and a second edition (DSM-II) came out in 1968, early
versions of the document were largely ignored.
Spitzer began work on the third version (DSM-III) in 1974, when the manual
was a spiral-bound paperback of a hundred and
fifty pages. It provided cursory descriptions of
about a hundred mental disorders, and was sold
primarily to large state mental institutions, for
three dollars and fifty cents. Under Spitzer’s
direction—which lasted through the DSM-III, published in 1980,
and the DSM-IIIR (“R”
for “revision”), published in 1987—both the girth
of the DSM and its
stature substantially increased. It is now nine
hundred pages, defines close to three hundred
mental illnesses, and sells hundreds of thousands
of copies, at eighty-three dollars each. But a
mere description of the physical evolution of the
DSM doesn’t fully
capture what Spitzer was able to accomplish. In
the course of defining more than a hundred mental
diseases, he not only revolutionized the practice
of psychiatry but also gave people all over the
United States a new language with which to
interpret their daily experiences and tame the
anarchy of their emotional lives.
The Biometrics Department of
the New York State Psychiatric Institute at
Columbia Presbyterian Medical Center is situated
in an imposing neo-Gothic building on West 168th
Street. I met Spitzer in the lobby, a sparsely
decorated and strangely silent place that doesn’t
seem to get much use. Spitzer, a tall, thin man
with well-cut clothes and a light step, was
brought up on the Upper West Side. He is in his
seventies but seems much younger; his graying hair
is dyed a deep shade of brown. He has worked at
Columbia for more than forty years, and his office
is filled with the debris of decades. Calligraphed
certificates with seals of red and gold cover the
walls, and his desk is overwhelmed by paper.
Spitzer first came to the university as a
resident and student at the Columbia Center for
Psychoanalytic Training and Research, after
graduating from N.Y.U. School of Medicine in 1957.
He had had a brilliant medical-school career,
publishing in professional journals a series of
well-received papers about childhood schizophrenia
and reading disabilities. He had also established
himself outside the academy, by helping to
discredit his erstwhile hero Reich. In addition to
his weekly sessions on the Lower East Side, the
teen-age Spitzer had persuaded another Reichian
doctor to give him free access to an orgone
accumulator, and he spent many hours sitting
hopefully on the booth’s tiny stool, absorbing
healing orgone energy, to no obvious avail. In
time, he became disillusioned, and in college he
wrote a paper critical of the therapy, which was
consulted by the Food and Drug Administration when
they later prosecuted Reich for fraud.
At Columbia Psychoanalytic, however, Spitzer’s
career faltered. Psychoanalysis was too abstract,
too theoretical, and somehow his patients rarely
seemed to improve. “I was always unsure that I was
being helpful, and I was uncomfortable with not
knowing what to do with their messiness,” he told
me. “I don’t think I was uncomfortable listening
and empathizing—I just didn’t know what the hell
to do.” Spitzer managed to graduate, and secured a
position as an instructor in the psychiatry
department (he has held some version of the job
ever since), but he is a man of tremendous drive
and ambition—also a devoted contrarian—and he
found teaching intellectually limiting. For
satisfaction, he turned to research. He worked on
depression and on diagnostic interview techniques,
but neither line of inquiry produced the radical
innovation or epic discovery that he would need to
make his name.
As Spitzer struggled to find his professional
footing in the nineteen-sixties, the still young
field of psychiatry was also in crisis. The
central issue involved the problem of diagnosis:
psychiatrists couldn’t seem to agree on who was
sick and what ailed them. A patient identified as
a textbook hysteric by one psychiatrist might
easily be classified as a hypochondriac depressive
by another. Blame for this discrepancy was
assigned to the DSM.
Critics claimed that the manual lacked what in the
world of science is known as “reliability”—the
ability to produce a consistent, replicable
result—and therefore also lacked scientific
validity. In order for any diagnostic instrument
to be considered useful, it must have both. The
S.A.T., for example, is viewed as reliable because
a person who takes the test on a Tuesday and gets
a score of 1200 will get a similar score if he
takes the test on a Thursday. It is considered
valid because scores are believed to correlate
with an external reality—“scholastic aptitude”—and
the test is seen as predictive of success in an
academic setting. Though validity is the more
important measure, it is impossible to achieve
validity without reliability: if you take the
S.A.T. on a Tuesday and get a 1200 and repeat it
on a Thursday and get a 600, the test is clearly
not able to gauge academic performance.
Reliability, therefore, is the threshold standard.
Problems with the reliability of psychiatric
diagnosis became evident during the Second World
War, when the military noticed that medical boards
in different parts of the country had dramatically
different rejection rates for men attempting to
enlist. A draft board in Wichita, say, might have
a twenty-per-cent exclusion rate, while Baltimore
might find sixty per cent of its applicants unfit
for service. Much of the disparity was on
psychiatric grounds, and this was puzzling. It
seemed implausible that the mental stability of
potential recruits would vary so greatly from one
area to another. A close study of the boards
eventually determined that the psychiatrists
responsible for making the decisions had widely
divergent criteria. So a hypothesis emerged:
perhaps it was not the young men but the doctors
who were the problem.
In 1949, the psychologist Philip Ash published
a study showing that three psychiatrists faced
with a single patient, and given identical
information at the same moment, were able to reach
the same diagnostic conclusion only twenty per
cent of the time. Aaron T. Beck, one of the
founders of cognitive behavioral therapy,
published a similar paper on reliability in 1962.
His review of nine different studies found rates
of agreement between thirty-two and forty-two per
cent. These were not encouraging numbers, given
that diagnostic reliability isn’t merely an
academic issue: if psychiatrists can’t agree on a
patient’s condition, then they can’t agree on the
treatment of that condition, and, essentially,
there’s no relationship between diagnosis and
cure. In addition, research depends on doctors’
ability to form homogeneous subject groups. How
can you test the effectiveness of a new drug to
treat depression if you can’t be sure that the
person you’re testing is suffering from that
disorder? Allen Frances, who worked under Spitzer
on the DSM-III and who,
in 1987, was appointed the director of the DSM-IV, says, “Without reliability
the system is completely random, and the diagnoses
mean almost nothing—maybe worse than nothing,
because they’re falsely labelling. You’re better
off not having a diagnostic system.”
Spitzer had no particular interest in
psychiatric diagnosis, but in 1966 he happened to
share a lunch table in the Columbia cafeteria with
the chairman of the DSM-II
task force. The two struck up a
conversation, got along well, and by the end of
the meal Spitzer had been offered the job of
note-taker on the DSM-II
committee. He accepted it, and served ably. He was
soon promoted, and when gay activists began to
protest the designation of homosexuality as a
pathology Spitzer brokered a compromise that
eventually resulted in the removal of
homosexuality from the DSM. Given the acrimony
surrounding the subject, this was an impressive
feat of nosological diplomacy, and in the early
seventies, when another revision of the DSM came due, Spitzer was
asked to be the chairman of the task force.
Today, the chair of the DSM task force is a coveted
post—people work for years to position themselves
as candidates—but in the early nineteen-seventies
descriptive psychiatry was a backwater. Donald
Klein, a panic expert at Columbia, who contributed
to the DSM-III, says,
“When Bob was appointed to the DSM-III, the job was of no
consequence. In fact, one of the reasons Bob got
the job was that it wasn’t considered that
important. The vast majority of psychiatrists, or
for that matter the A.P.A., didn’t expect anything
to come from it.” This attitude was particularly
prevalent among Freudian psychoanalysts, who were
the voice of the mental-health profession for much
of the twentieth century. They saw descriptive
psychiatry as narrow, bloodless, and without real
significance. “Psychoanalysts dismiss symptoms as
being unimportant, and they say that the real
thing is the internal conflicts,” Klein says. “So
to be interested in descriptive diagnosis was to
be superficial and a little bit stupid.”
Spitzer, however, managed to
turn this obscurity to his advantage. Given
unlimited administrative control, he established
twenty-five committees whose task it would be to
come up with detailed descriptions of mental
disorders, and selected a group of psychiatrists
who saw themselves primarily as scientists to sit
on those committees. These men and women came to
be known in the halls of Columbia as dops, for “data-oriented
people.” They were deeply skeptical of
psychiatry’s unquestioning embrace of Freud.
“Rather than just appealing to authority, the
authority of Freud, the appeal was: Are there
studies? What evidence is there?” Spitzer says.
“The people I appointed had all made a commitment
to be guided by data.” Like Spitzer, Jean
Endicott, one of the original members of the DSM-III task force, felt
frustrated with the rigid dogmatism of
psychoanalysis. She says, “For us dops, it was like, Come
on—let’s get out of the nineteenth century! Let’s
move into the twentieth, maybe the twenty-first,
and apply what we’ve learned.”
There was just one problem with this utopian
vision of better psychiatry through science: the
“science” hadn’t yet been done. “There was very
little systematic research, and much of the
research that existed was really a
hodgepodge—scattered, inconsistent, and
ambiguous,” Theodore Millon, one of the members of
the DSM-III task force, says. “I think
the majority of us recognized that the amount of
good, solid science upon which we were making our
decisions was pretty modest.” Members of the
various committees would regularly meet and
attempt to come up with more specific and
comprehensive descriptions of mental disorders.
David Shaffer, a British psychiatrist who worked
on the DSM-III and the
DSM-IIIR, told me that
the sessions were often chaotic. “There would be
these meetings of the so-called experts or
advisers, and people would be standing and sitting
and moving around,” he said. “People would talk on
top of each other. But Bob would be too busy
typing notes to chair the meeting in an orderly
way.” One participant said that the haphazardness
of the meetings he attended could be
“disquieting.” He went on, “Suddenly, these things
would happen and there didn’t seem to be much
basis for it except that someone just decided all
of a sudden to run with it.” Allen Frances agrees
that the loudest voices usually won out. Both he
and Shaffer say, however, that the process
designed by Spitzer was generally sound. “There
was not another way of doing it, no extensive
literature that one could turn to,” Frances says.
According to him, after the meetings Spitzer would
retreat to his office to make sense of the
information he’d collected. “The way it worked was
that after a period of erosion, with different
opinions being condensed in his mind, a list of
criteria would come up,” Frances says. “It would
usually be some combination of the accepted wisdom
of the group, as interpreted by Bob, with a little
added weight to the people he respected most, and
a little bit to whoever got there last.”
Because there are very few records of the
process, it’s hard to pin down exactly how Spitzer
and his staff determined which mental disorders to
include in the new manual and which to reject.
Spitzer seems to have made many of the final
decisions with minimal consultation. “He must have
had some internal criteria,” Shaffer says. “But I
don’t always know what they were.” One afternoon
in his office at Columbia, I asked Spitzer what
factors would lead him to add a new disease. “How
logical it was,” he said, vaguely. “Whether it fit
in. The main thing was that it had to make sense.
It had to be logical.” He went on, “For most of
the categories, it was just the best thinking of
people who seemed to have expertise in the
area.”
Not every mental disorder made the final cut.
For instance, a group of child psychiatrists
aspired to introduce a category they called
“atypical child”—an idea that, according to
Spitzer, didn’t survive the first meeting. “I kept
saying, ‘O.K., how would you define “atypical
child”?’ And the answer was ‘Well, it’s very
difficult to define, because these kids are all
very different.’ ” As a general rule, though,
Spitzer was more interested in including mental
disorders than in excluding them. “Bob never met a
new diagnosis that he didn’t at least get
interested in,” Frances says. “Anything, however
against his own leanings that might be, was a new
thing to play with, a new toy.” In 1974, Roger
Peele and Paul Luisada, psychiatrists at St.
Elizabeths Hospital, in Washington, D.C., wrote a
paper in which they used the term “hysterical
psychoses” to describe the behavior of two kinds
of patients they had observed: those who suffered
from extremely short episodes of delusion and
hallucination after a major traumatic event, and
those who felt compelled to show up in an
emergency room even though they had no genuine
physical or psychological problems. Spitzer read
the paper and asked Peele and Luisada if he could
come to Washington to meet them. During a
forty-minute conversation, the three decided that
“hysterical psychoses” should really be divided
into two disorders. Short episodes of delusion and
hallucination would be labelled “brief reactive
psychosis,” and the tendency to show up in an
emergency room without authentic cause would be
called “factitious disorder.” “Then Bob asked
for a typewriter,” Peele says. To Peele’s
surprise, Spitzer drafted the definitions on the
spot. “He banged out criteria sets for factitious
disorder and for brief reactive psychosis, and it
struck me that this was a productive fellow! He
comes in to talk about an issue and walks away
with diagnostic criteria for two different mental
disorders!” Both factitious disorder and brief
reactive psychosis were included in the DSM-III with only minor
adjustments.
The process of identifying new disorders wasn’t
usually so improvisatory, though, and it is
certain that psychiatric treatment was
significantly improved by the designation of many
of the new syndromes. Attention-deficit disorder,
autism, anorexia nervosa, bulimia, panic disorder,
and post-traumatic stress disorder are all
examples of diseases added during Spitzer’s tenure
which now receive specialized treatment. But by
far the most radical innovation in the new DSM—and certainly the one that
got the most attention in the psychiatric
community—was that, alongside the greatly expanded
prose descriptions for each disorder, Spitzer
added a checklist of symptoms that should be
present in order to justify a diagnosis. For
example, the current DSM
describes a person with obsessive-compulsive
personality disorder as someone who:
—is preoccupied
with details, rules, lists, order, organization,
or schedules to the extent that the major point of
the activity is lost. . . .
—is unable to discard worn-out or
worthless objects even when they have no
sentimental value. . . .
—adopts a miserly spending style
towards both self and others.
Five other criteria are listed in a box beneath
the description of the disorder, and clinicians
are cautioned that at least four of the eight must
be present in order for the label to be applied.
Finally, Spitzer and the dops argued, here was the
answer to the problem of reliability, the issue
that had bedevilled psychiatry for years. As they
understood it, there were two reasons that doctors
couldn’t agree on a diagnosis. The first was
informational variance: because of rapport or
interview style, different doctors get different
information from the same patient. The second was
interpretive variance: each doctor carries in his
mind his own definition of what a specific disease
looks like. One goal of the DSM-III was to reduce interpretive
variance by standardizing definitions. Spitzer’s
team reasoned that if a clear set of criteria were
provided, diagnostic reliability would inevitably
improve. They also argued that the criteria would
enable mental-health professionals to communicate,
and greatly facilitate psychiatric research. But
the real victory was that each mental disorder
could now be identified by a foolproof little
recipe.
Spitzer labored over the DSM-III for six years, often
working seventy or eighty hours a week. “He’s kind
of an idiot savant of diagnosis—in a good sense,
in the sense that he never tires of it,” Allen
Frances says. John Talbott, a former president of
the American Psychiatric Association, who has been
friends with Spitzer for years, says, “I remember
the first time I saw him walk into a breakfast at
an A.P.A. meeting in a jogging suit, sweating, and
having exercised. I was taken aback. The idea that
I saw Bob Spitzer away from his suit and computer
was mind-shattering.” But Spitzer’s dedication
didn’t always endear him to the people he worked
with. “He was famous for walking down a crowded
hallway and not looking left or right or saying
anything to anyone,” one colleague recalled. “He
would never say hello. You could stand right next
to him and be talking to him and he wouldn’t even
hear you. He didn’t seem to recognize that anyone
was there.”
Despite Spitzer’s genius at describing the
particulars of emotional behavior, he didn’t seem
to grasp other people very well. Jean Endicott,
his collaborator of many years, says, “He got very
involved with issues, with ideas, and with
questions. At times he was unaware of how people
were responding to him or to the issue. He was
surprised when he learned that someone was
annoyed. He’d say, ‘Why was he annoyed? What’d I
do?’ ” After years of confrontations, Spitzer is
now aware of this shortcoming, and says that he
struggles with it in his everyday life. “I find it
very hard to give presents,” he says. “I never
know what to give. A lot of people, they can see
something and say, ‘Oh, that person would like
that.’ But that just doesn’t happen to me. It’s
not that I’m stingy. I’m just not able to project
what they would like.” Frances argues that
Spitzer’s emotional myopia has benefitted him in
his chosen career: “He doesn’t understand people’s
emotions. He knows he doesn’t. But that’s actually
helpful in labelling symptoms. It provides less
noise.”
What may have been a professional strength had
disruptive consequences in Spitzer’s personal
life. In 1958, he married a doctor, and they had
two children. As the demands of his project
mounted, he spent less and less time with his
family, and eventually fell in love with Janet
Williams, an attractive, outspoken social worker
he had hired to help edit the manual. In 1979, he
and his wife separated, and several years later
Spitzer and Williams were married. Williams became
a professor at Columbia, and she and Spitzer went
on to have three children. Spitzer remained close
to his oldest son, but his relationship with his
daughter from his first marriage was initially
strained by the divorce.
The DSM was scheduled
to be published in 1980, which meant that Spitzer
had to have a draft prepared in the spring of
1979. Like any major American Psychiatric
Association initiative, the DSM had to be ratified by the
assembly of the A.P.A., a decision-making body
composed of elected officials from all over the
country. Spitzer’s anti-Freudian ideas had caused
resentment throughout the production process, and,
as the date of the assembly approached, the
opposition gathered strength and narrowed its
focus to a single, crucial word—“neurosis”—which
Spitzer wanted stricken from the DSM.
The term “neurosis” has a very long history,
but over the course of the twentieth century it
became inseparable from Freudian psychoanalytic
philosophy. A neurosis, Freud believed, emerged
from unconscious conflict. This was the bedrock
psychoanalytic concept at the height of the
psychoanalytic era, and both the DSM-I and the DSM-II made frequent use of the
term. Spitzer and the dops,however, reasoned that,
because a wide range of mental-health
professionals were going to use the manual in
everyday practice, the DSM could not be aligned with
any single theory. They decided to restrict
themselves simply to describing behaviors that
were visible to the human eye: they couldn’t tell
you why someone developed obsessive-compulsive
personality disorder, but they were happy to
observe that such a person is often
“over-conscientious, scrupulous, and inflexible
about matters of morality.”
When word of Spitzer’s intention to eliminate
“neurosis” from the DSM
got out, Donald Klein says, “people were aghast.
‘Neurosis’ was the bread-and-butter term of
psychiatry, and people thought that we were
calling into question their livelihood.” Roger
Peele, of St. Elizabeths, was sympathetic to
Spitzer’s work, but, as a representative of the
Washington, D.C., branch of the A.P.A., he felt a
need to challenge Spitzer on behalf of his
constituency. “The most common diagnosis in
private practices in Washington, D.C., in the
nineteen-seventies was something called depressive
neurosis,” Peele says. “That was what they were
doing day after day.” Psychoanalysts bitterly
denounced the early drafts. One psychiatrist,
Howard Berk, wrote a letter to Spitzer saying that
“the DSM-III gets rid of
the castle of neurosis and replaces it with a
diagnostic Levittown.”
Without the support of the psychoanalysts, it
was possible that the DSM-III wouldn’t pass the
assembly and the entire project would come to
nothing. The A.P.A. leadership got involved,
instructing Spitzer and the dops to include
psychoanalysts in their deliberations. After
months of acrimonious debate, Spitzer and the
psychoanalysts were able to reach a compromise:
the word “neurosis” was retained in discreet
parentheses in three or four key categories.
With this issue resolved, Spitzer presented the
final draft of the DSM-III to the A.P.A. assembly in
May of 1979. Roughly three hundred and fifty
psychiatrists gathered in a large auditorium in
Chicago. Spitzer got up onstage and reviewed the
DSM process and what
they were trying to accomplish, and there was a
motion to pass it. “Then a rather remarkable thing
happened,” Peele says. “Something that you don’t
see in the assembly very often. People stood up
and applauded.” Peele remembers watching shock
break over Spitzer’s face. “Bob’s eyes got watery.
Here was a group that he was afraid would torpedo
all his efforts, and instead he gets a standing
ovation.”
The DSM-III and the DSM-IIIR together sold more than a
million copies. Sales of the DSM-IV (1994) also exceeded a
million, and the DSM-IV
TR (for “text revision”), the most recent
iteration of the DSM,
has sold four hundred and twenty thousand copies
since its publication, in 2000. Its success
continues to grow. Today, there are forty DSM-related products available
on the Web site of the American Psychiatric
Association. Stuart Kirk, a professor of public
policy at U.C.L.A., and Herb Kutchins, a professor
emeritus of social work at California State
University, Sacramento, have studied the creation
of the modern DSM for
more than seventeen years, and they argue that its
financial and academic success can be attributed
to Spitzer’s skillful salesmanship. According to
Kirk and Kutchins, immediately after the
publication of the DSM-III Spitzer embarked on a
P.R. campaign, touting its reliability as “far
greater” and “higher than previously achieved” and
“extremely good.” “For the first time . . .
claims were made that the new manual was
scientifically sound,” they write in “Making Us
Crazy: DSM—The Psychiatric Bible and the Creation
of Mental Disorders” (1997). Gerald Klerman, a
prominent psychiatrist, published an influential
book in 1986 that flatly announced, “The
reliability problem has been solved.”
It was largely on the basis of statements like
these that the new DSM
was embraced by psychiatrists and psychiatric
institutions all over the globe. “The DSM
revolution in reliability is a revolution in
rhetoric, not in reality,” Kutchins and Kirk
write. Kirk told me, “No one really scrutinized
the science very carefully.” This was owing, in
part, to the manual’s imposing physical
appearance. “One of the objections was that it
appeared to be more authoritative than it was. The
way it was laid out made it seem like a textbook,
as if it was a depository of all known facts,”
David Shaffer says. “The average reader would feel
that it carried great authority and weight, which
was not necessarily merited.”
Almost immediately, the book started to turn up
everywhere. It was translated into thirteen
languages. Insurance companies, which expanded
their coverage as psychotherapy became more
widespread in the nineteen-seventies, welcomed the
DSM-III as a standard. But it was
more than that: the DSM
had become a cultural phenomenon. There were
splashy stories in the press, and TV news
magazines showcased several of the newly
identified disorders. “It was a runaway success in
terms of publicity,” Allen Frances says. Spitzer,
Williams, and the rest of the dops were surprised and
pleased by the reception. “For us it was kind of
like being rock stars,” Williams says. “Because
everyone saw that it was the next big thing,
everyone knew us and wanted to talk to us. It was
like suddenly being the most popular kid on the
block.”
A year and a half after the publication of the
DSM-III, Spitzer began work on its
revision. Emboldened by his success, he became
still more adamant about his opinions, and made
enemies of a variety of groups. “I love
controversy,” Spitzer admits, “so if there was
something that I thought needed to be added that
was controversial, so much the better.” He enraged
feminists when he tried to include a diagnosis
termed “masochistic personality disorder,” a
nonsexual form of masochism which critics claimed
implied that some abused wives might be
responsible for their own mistreatment. He angered
women’s groups again when he attempted to
designate PMS as a mental disorder (“pre-menstrual
dysphoric disorder”). “A lot of what’s in the
DSM represents what Bob
thinks is right,” Michael First, a psychiatrist at
Columbia who worked on both the DSM-IIIR and DSM-IV, says. “He really saw
this as his book, and if
he thought it was right he would push very hard to
get it in that way.” Thus, despite the success of
Spitzer’s two editions, and despite extensive
lobbying on his part, the American Psychiatric
Association gave the chairmanship of the DSM-IV task force to Allen
Frances. “The American Psychiatric Association
decided that they had had enough of Spitzer, and I
can understand that,” Spitzer says with a note of
regret in his voice. “I think that there was a
feeling that if the DSM
was going to represent the entire profession—which
obviously it has to—it would be good to have
someone else.” This certainly was part of the
reason. But Spitzer’s colleagues believe that the
single-mindedness with which he transformed the
DSM also contributed to
his eclipse. “I think that Spitzer looked better
in III than he did in
IIIR,” Peele says.
“IIIR, for one reason or
another, came across as more heavy-handed—‘Spitzer
wants it this way!’ ”
As chair of the DSM-IV, Frances quickly set about
constructing a more transparent process. Power was
decentralized, there were systematic literature
reviews, and the committees were put on notice
that, as Frances says, “the wild growth and casual
addition” of new mental disorders were to be
avoided. Spitzer was made special adviser to the
DSM-IV task force, but his power
was dramatically reduced. He found the whole
experience profoundly distressing. “I had the
feeling that this wonderful thing that I created
was going to be destroyed,” he says.
The official position of the
American Psychiatric Association is that the
reliability of the DSM
is sound. Darrel Regier, the director of research
at the A.P.A., says, “Reliability is, of course,
improved. Because you have the criteria, you’re
not depending on untestable theories of the cause
of a diagnosis.” He says that psychiatric practice
was so radically changed by Spitzer’s DSM—it was, for the first
time, at least nominally evidence-based—that it’s
impossible to compare reliability before and
after. One consequence of the addition of
diagnostic criteria was the creation of long,
structured interviews, which have allowed
psychiatrists successfully to assemble homogeneous
research populations for clinical trials. In this
context, the DSM
diagnoses have been found to be reliable.
But structured interviews don’t always have
much in common with the conversations that take
place in therapists’ offices, and since the
publication of the DSM-III, in 1980, no major
study has been able to demonstrate a substantive
improvement in reliability in those less formal
settings. During the production of the DSM-IV, the American Psychiatric
Association received funding from the MacArthur
Foundation to undertake a broad reliability study,
and although the research phase of the project was
completed, the findings were never published. The
director of the project, Jim Thompson, says that
the A.P.A. ran out of money. Another study, whose
primary author was Spitzer’s wife, Janet Williams,
took place at six sites in the United States and
one in Germany. Supervised by Williams and some of
the most experienced diagnostic professionals in
the world, the participating clinicians were given
extensive special training before being split into
pairs and asked to interview nearly six hundred
prospective patients. The idea was to determine
whether clinicians faced with the same client
could agree on a diagnosis using the DSM. Although Williams claims
that the study supported the reliability of the
DSM, when the
investigators wrote up their results they admitted
that they “had expected higher reliability
values.” In fact, Kutchins and Kirk point out, the
results were “not that different from those
statistics achieved in the 1950s and 1960s—and in
some cases were worse.”
Reliability is probably lowest in the place
where the most diagnoses are made: the therapist’s
office. As Tom Widiger, who served as head of
research for the DSM-IV, points out, “There are
lots of studies which show that clinicians
diagnose most of their patients with one
particular disorder and really don’t
systematically assess for other disorders. They
have a bias in reference to the disorder that they
are especially interested in treating and believe
that most of their patients have.” Unfortunately,
because psychiatry and its sister disciplines
stand under the authoritative banner of science,
consumers are often reluctant to challenge the
labels they are given. Diagnoses are frequently
liberating, helping a person to understand that
what he views as a personal failing is actually a
medical problem, but they can in certain cases
become self-fulfilling prophecies. A child
inappropriately given the label of
attention-deficit/hyperactivity disorder can come
to see himself as broken or limited, and act
accordingly. And there are other problems with the
DSM. Critics complain
that it often characterizes everyday behaviors as
abnormal, and that it continues to lack validity,
whether or not the issue of reliability has been
definitely resolved.
Even some of the manual’s early advocates now
think that the broad claims of reliability were
exaggerated. “To my way of thinking, the
reliability of the DSM—although improved—has been
oversold by some people,” Allen Frances says.
“From a cultural standpoint, reliability was a way
of authenticating the DSM as a radical innovation.”
He adds, “In a vacuum, to create criteria that
were based on accepted wisdom as a first stab was
fine, as long as you didn’t take it too seriously.
The processes that happened were very limited, but
they were valuable in their context.” And Frances
believes that both psychiatry and the public have
benefitted in a less tangible way from the
collective fantasy that the DSM was a genuine scientific
tool. “In my view, if I had been doing the DSM-III it would never have been
as famous a document, because I’m a skeptic,” he
says. “But it was good for the world at large.
Good for psychiatry, good for patients. Good for
everyone at that point in time to have someone
whose view may have been more simpleminded than
the world really is. A more complex view of life
at that point would have resulted in a ho-hum ‘We
have this book and maybe it will be useful in our
field.’ The revolution came not just from the
material itself, from the substance of it, but
from the passion with which it was introduced.”
Spitzer, too, has grown more circumspect. “To
say that we’ve solved the reliability problem is
just not true,” he told me one afternoon in his
office at Columbia. “It’s been improved. But if
you’re in a situation with a general clinician
it’s certainly not very good. There’s still a real
problem, and it’s not clear how to solve the
problem.” His personal investment in the DSM remains intense. During
one of our conversations, I asked Spitzer if he
ever feels a sense of ownership when troubled
friends speak to him of their new diagnoses, or
perhaps when he comes across a newspaper account
that features one of the disorders to which he
gave so much of his life. He admitted that he does
on occasion feel a small surge of pride. “My
fingers were on the typewriter that typed those.
They might have been changed somewhat, but they
all went through my fingers,” he said. “Every
word.”